Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 an... by Jonathan I. Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E. Pink, Yousef Binamer, Brad Glick, Petra Staubach, Brian Calimlim, Chao Li, Ayman Grada, Alvaro Moreira, Wan-Ju Lee, Andreas Wollenberg

Get full text

Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis by Jonathan I. Silverberg, Melinda Gooderham, Andreas Wollenberg, Andrew E. Pink, Diego Ruiz Dasilva, Shawn G. Kwatra, Yousef Binamer, Norito Katoh, Valeria Aoki, Alvaro Moreira, Ayman Grada, Chao Li, Brian Calimlim, Wan-Ju Lee, Christopher G. Bunick

Get full text

Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Tria... by Eric L. Simpson, Jonathan I. Silverberg, Vimal H. Prajapati, Kilian Eyerich, Norito Katoh, Mark Boguniewicz, Emma Guttman-Yassky, E. James Song, Wan-Ju Lee, Henrique D. Teixeira, Tianshuang Wu, Cristina Sancho Sanchez, Namita Vigna, Brian M. Calimlim, Marjolein de Bruin-Weller

Get full text

Questionnaire survey among ophthalmic allergists on dupilumab-associated ocular surface disease in Japan by Jun Shoji, Yousuke Asada, Rumi Adachi, Noriko Inada, Eiichi Uchio, Yoko Kataoka, Norito Katoh, Tatsuma Kishimoto, Eisuke Shimizu, Tamaki Sumi, Etsuko Takamura, Kenichi Namba, Yuuko Hara, Kazuhiro Harada, Akira Hirota, Atsuki Fukushima, Ken Fukuda, Hiroshi Fujishima, Moe Matsuzawa, Akira Matsuda, Tatsuya Mimura, Dai Miyazaki, Hiroyuki Yazu, Kaori Yamamoto, Kazuma Kitsu, Nobuyuki Ebihara

Get full text